Jefferies

Jefferies is a global investment bank rather than a venture fund, with healthcare exposure primarily through its equity capital markets, M&A, and leveraged finance practices rather than direct equity investing. The firm does deploy balance sheet capital selectively into late-stage and pre-IPO companies through its merchant banking and principal investment groups, with checks typically in the $10M to $50M range as part of crossover or strategic rounds. Founders should treat Jefferies primarily as an investment banking partner for IPO, M&A, and follow-on equity raises rather than as a venture investor. Healthcare focus at the bank is meaningful and well-resourced, with a strong healthcare equity research and capital markets practice covering biotech, medical devices, digital health, and healthcare services. AI focus is welcome at the bank’s healthcare technology practice. Founders best suited for a Jefferies banking relationship are growth and late-stage CEOs preparing for IPO, M&A, or large private rounds, with $50M-plus revenue or compelling biotech platforms. Founders who do not fit a banking relationship include seed and Series A teams. The entry path for banking is warm introduction through a healthcare equity capital markets or M&A banker at Jefferies, a healthcare crossover investor, or a portfolio CEO. For potential principal investments, the path runs through the merchant banking or strategic investment teams. Founders should weight Jefferies as a banking partner first and a capital source second, and pair any principal investment conversation with a clear public-market or M&A timeline.